Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-14

Clinical Trial Update: NightWare Randomized Trial 02 [NA]

View source ↗

Summary

NightWare announces the completion of its randomized Trial 02 evaluating its therapy for post-traumatic stress-related nightmares. The study covered conditions …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NightWare

Snippet

Sponsor: NightWare | Conditions: Stress Disorders, Post-Traumatic, Combat Disorders | NA | Status: COMPLETED